pigenetic modifications are important drivers of development, health, and disease. DNA methylation is one type of epigenetic mark that can be measured in blood or other human samples. DNA methylation marks are associated with genetics and environmental exposures, which represents a useful tool for public health and medicine.

This presentation will give an overview of current technologies for DNA methylation measurements, describe methodological challenges associated with these methods, and provide evidence-based opportunities for future DNA methylation studies.

Kelly M. Bakulski, Ph.D. is an Assistant Professor in the Department of Epidemiology at the University of Michigan School of Public Health. Dr. Bakulski’s research goal is to understand the environmental and genetic etiologies of neurological disorders, including autism spectrum disorder and Alzheimer’s disease.

Dr. Bakulski incorporates population approaches and laboratory experiments to develop biomarker and cell type tools to better inform epigenetic inferences.

CME credit is available to physicians.